A detailed history of Aristotle Capital Management, LLC transactions in Novartis Ag stock. As of the latest transaction made, Aristotle Capital Management, LLC holds 1,794 shares of NVS stock, worth $174,161. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,794
Previous 1,972 9.03%
Holding current value
$174,161
Previous $209,000 1.44%
% of portfolio
0.0%
Previous 0.0%

Shares

39 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$106.13 - $120.89 $18,891 - $21,518
-178 Reduced 9.03%
1,794 $206,000
Q2 2024

Aug 14, 2024

SELL
$92.57 - $107.37 $41.1 Million - $47.7 Million
-444,417 Reduced 99.56%
1,972 $209,000
Q1 2024

May 15, 2024

SELL
$95.27 - $108.47 $13.9 Million - $15.8 Million
-145,946 Reduced 24.64%
446,389 $43.2 Million
Q4 2023

Feb 14, 2024

BUY
$92.27 - $101.54 $274,872 - $302,487
2,979 Added 0.51%
592,335 $59.8 Million
Q3 2023

Nov 14, 2023

BUY
$94.73 - $105.13 $245,729 - $272,707
2,594 Added 0.44%
589,356 $60 Million
Q2 2023

Aug 14, 2023

BUY
$92.52 - $104.91 $1.45 Million - $1.64 Million
15,635 Added 2.74%
586,762 $59.2 Million
Q1 2023

May 15, 2023

BUY
$80.03 - $92.81 $620,552 - $719,648
7,754 Added 1.38%
571,127 $52.5 Million
Q4 2022

Feb 14, 2023

SELL
$75.55 - $92.52 $1.7 Million - $2.08 Million
-22,494 Reduced 3.84%
563,373 $51.1 Million
Q3 2022

Nov 14, 2022

SELL
$74.61 - $87.26 $686,785 - $803,228
-9,205 Reduced 1.55%
585,867 $44.5 Million
Q2 2022

Aug 15, 2022

BUY
$80.52 - $93.75 $771,623 - $898,406
9,583 Added 1.64%
595,072 $50.3 Million
Q1 2022

May 16, 2022

BUY
$80.11 - $90.62 $1.86 Million - $2.11 Million
23,280 Added 4.14%
585,489 $51.4 Million
Q4 2021

Feb 14, 2022

SELL
$79.7 - $88.13 $603 Million - $667 Million
-7,565,477 Reduced 93.08%
562,209 $49.2 Million
Q3 2021

Nov 15, 2021

BUY
$81.78 - $95.14 $5.04 Million - $5.86 Million
61,589 Added 0.76%
8,127,686 $665 Million
Q2 2021

Aug 16, 2021

BUY
$85.24 - $94.15 $13.4 Million - $14.8 Million
157,444 Added 1.99%
8,066,097 $736 Million
Q1 2021

May 17, 2021

BUY
$83.5 - $98.47 $66 Million - $77.8 Million
790,589 Added 11.11%
7,908,653 $676 Million
Q4 2020

Feb 22, 2021

BUY
$78.07 - $94.43 $101 Million - $122 Million
1,295,968 Added 22.26%
7,118,064 $672 Million
Q4 2020

Feb 16, 2021

SELL
$78.07 - $94.43 $73.2 Million - $88.5 Million
-937,397 Reduced 13.87%
5,822,096 $550 Million
Q3 2020

Nov 16, 2020

BUY
$82.14 - $91.0 $15.7 Million - $17.4 Million
190,861 Added 2.91%
6,759,493 $588 Million
Q2 2020

Aug 14, 2020

BUY
$80.93 - $91.1 $55.5 Million - $62.5 Million
685,903 Added 11.66%
6,568,632 $574 Million
Q1 2020

May 15, 2020

BUY
$70.67 - $99.01 $6.68 Million - $9.36 Million
94,561 Added 1.63%
5,882,729 $485 Million
Q4 2019

Feb 14, 2020

BUY
$84.35 - $95.37 $192 Million - $217 Million
2,277,806 Added 64.89%
5,788,168 $548 Million
Q3 2019

Nov 14, 2019

BUY
$85.54 - $94.26 $9.72 Million - $10.7 Million
113,682 Added 3.35%
3,510,362 $305 Million
Q2 2019

Aug 14, 2019

SELL
$75.4 - $92.8 $7.8 Million - $9.6 Million
-103,404 Reduced 2.95%
3,396,680 $310 Million
Q1 2019

May 15, 2019

BUY
$75.32 - $86.15 $32.5 Million - $37.2 Million
431,829 Added 14.07%
3,500,084 $336 Million
Q4 2018

Feb 14, 2019

SELL
$73.66 - $82.02 $43.6 Million - $48.6 Million
-592,015 Reduced 16.17%
3,068,255 $263 Million
Q3 2018

Nov 14, 2018

SELL
$66.94 - $77.43 $1.59 Million - $1.84 Million
-23,770 Reduced 0.65%
3,660,270 $315 Million
Q2 2018

Sep 19, 2019

SELL
$64.91 - $73.36 $4.41 Million - $4.99 Million
-68,000 Reduced 1.81%
3,684,040 $278 Million
Q2 2018

Aug 14, 2018

BUY
$64.91 - $73.36 $22.9 Million - $25.9 Million
352,399 Added 10.37%
3,752,040 $283 Million
Q1 2018

May 15, 2018

BUY
$70.39 - $84.15 $14.4 Million - $17.2 Million
204,507 Added 6.4%
3,399,641 $275 Million
Q4 2017

Feb 14, 2018

BUY
$72.33 - $77.64 $15.6 Million - $16.7 Million
215,584 Added 7.24%
3,195,134 $268 Million
Q3 2017

Nov 14, 2017

SELL
$74.14 - $77.27 $642,942 - $670,085
-8,672 Reduced 0.29%
2,979,550 $256 Million
Q2 2017

Nov 16, 2017

BUY
N/A
114,668 Added 3.99%
2,988,222 $249 Million
Q1 2017

Nov 16, 2017

BUY
N/A
112,153 Added 4.06%
2,873,554 $213 Million
Q4 2016

Nov 16, 2017

BUY
N/A
45,033 Added 1.66%
2,761,401 $201 Million
Q3 2016

Nov 16, 2017

SELL
N/A
-20,826 Reduced 0.76%
2,716,368 $214 Million
Q2 2016

Nov 16, 2017

BUY
N/A
662,350 Added 31.92%
2,737,194 $226 Million
Q1 2016

Nov 17, 2017

BUY
N/A
187,534 Added 9.94%
2,074,844 $150 Million
Q4 2015

Nov 16, 2017

BUY
N/A
74,395 Added 4.1%
1,887,310 $162 Million
Q3 2015

Nov 16, 2017

BUY
N/A
1,812,915
1,812,915 $167 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $209B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Aristotle Capital Management, LLC Portfolio

Follow Aristotle Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aristotle Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aristotle Capital Management, LLC with notifications on news.